← Research library

Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys

Animal research · 2015

What was studied
Nine old rhesus monkeys: five Pancragen, four glimepiride
Main finding
Compared glucose and endocrine responses with glimepiride; the groups showed different insulin/C-peptide patterns.

Reported findings and study design

Nine aged female rhesus macaques underwent glucose tolerance testing. Five received Pancragen 0.05 mg per animal intramuscularly each day for 10 days. Four received oral glimepiride 4 mg per animal daily for 10 days.

Population or model Nine old rhesus monkeys: five Pancragen, four glimepiride

Results · Original journal abstract indexed by PubMed
MeasureResultComparison, timing and statistics
Basal glucoseDecreased in both groups.
Insulin and C-peptide during glucose testingThe authors reported normalization with Pancragen. Glimepiride had a later glucose-lowering effect and stimulated C-peptide, with no significant effect on insulin secretion. The abstract does not give the effect sizes.

Source for these results ↗ · Reviewed 2026-11-16

Study limitations and source details

Study limitations

  • Very small animal comparison; not a head-to-head human diabetes trial.
  • Full methods, adverse-event reporting and independent replication remain to be appraised.

Source details

Journal publication

Europe PMC indexed citation and abstract checked. Full original paper not reviewed.

Sources checked

Citation

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology

Animal / experimentalEnglish abstract

Goncharova ND, Ivanova LG, Oganyan TE, Vengerin AA, Khavinson VK. Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys Advances in gerontology = Uspekhi gerontologii 28(3):579-585. PMID 28509500

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards